Bulent Aksoy to Neoplasms, Experimental
This is a "connection" page, showing publications Bulent Aksoy has written about Neoplasms, Experimental.
Connection Strength
0.150
-
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy. J Clin Invest. 2019 02 25; 129(4):1551-1565.
Score: 0.150